E
Psyence Biomedical Ltd. PBM
$0.5333 -$0.0165-3.00% NASDAQ
Recommendation
Prev Close
$0.5498
Volume
51,839
Avg Vol (90D)
1,429,549
Market Cap
$2.43M
Dividend & Yield
--
52-Week Range
$0.3666 - $108.00
P/E (TTM)
--
EPS (TTM)
-$270.58
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Harraden Circle Investments LLC Purchases Shares of 182,323 Psyence Biomedical Ltd. (NASDAQ:PBM)
4/18/2025 - Ticker Report
Psyence Biomedical (PBM) Initiates Reverse Stock Split to Meet Nasdaq Compliance
4/18/2025 - GuruFocus
Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
4/17/2025 - Newsfile Corp. - News Releases
Psyence Group Announces Share Consolidation
4/17/2025 - Globe Newswire
Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement
4/15/2025 - Newsfile Corp. - News Releases
Psyence Biomedical Transitions CRO for Psilocybin Trial in April 2025
4/11/2025 - TipRanks Financial Blog
Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia
4/8/2025 - Newsfile Corp. - News Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
3/31/2025 - Newsfile Corp. - News Releases
Psyence Biomedical Announces Special Shareholder Meeting for Share Consolidation
3/31/2025 - TipRanks Financial Blog
Short Interest in Psyence Biomedical Ltd. (NASDAQ:PBM) Decreases By 24.7%
3/30/2025 - Ticker Report
Psyence Biomedical Enhances Scientific Advisory Board with New Appointment
3/25/2025 - TipRanks Financial Blog
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein
3/25/2025 - Globe Newswire
Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein
3/18/2025 - Newsfile Corp. - News Releases
Essential Planning LLC. Takes $163,000 Position in Psyence Biomedical Ltd. (NASDAQ:PBM)
3/14/2025 - Ticker Report
Psyence Biomedical Strengthens Research with New Advisory Board Chair
3/10/2025 - TipRanks Financial Blog
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board
3/10/2025 - Globe Newswire
Psyence Biomedical files to sell 13.81M common shares for holders
3/4/2025 - The Fly
Psyence Biomedical files $75M mixed securities shelf
3/4/2025 - The Fly
Psyence Biomedical names Garcia-Romeu as chair of SAB
2/26/2025 - The Fly
Psyence Biomed Names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board
2/26/2025 - Globe Newswire
Short Interest in Psyence Biomedical Ltd. (NASDAQ:PBM) Declines By 22.3%
2/14/2025 - Ticker Report
Hudson Bay Capital Management LP Acquires Shares in Psyence Biomedical Ltd
2/11/2025 - GuruFocus
Psyence Biomedical files to sell 3.075M common shares for holders
1/24/2025 - TipRanks Financial Blog
Psyence Biomedical files to sell 3.075M common shares for holders
1/24/2025 - The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$3.40M
EBIT (TTM)
-$3.41M
Net Income (TTM)
-$47.92M
Balance Sheet
Total Assets (Q)
$2.25M
Total Debt (Q)
$1.30M
Total Liabilities (Q)
$3.51M
Book Value Per Share (Q)
-$2.07
Cash Flow
Cash from Operations (TTM)
-$2.86M
Cash from Investing (TTM)
-$12.20K
Cash from Financing (TTM)
$4.21M
Net Change in Cash (TTM)
$1.34M
Filings
Filing Date
Thursday, January 23, 2025
Period Date
Monday, September 30, 2024
Next Filing
End of July (est)
Price History
Loading...
Beta
1.34
7-Day Total Return
14.74%
30-Day Total Return
-31.97%
60-Day Total Return
-67.08%
90-Day Total Return
-71.17%
Year to Date Total Return
-74.36%
1-Year Total Return
-99.17%
2-Year Total Return
-99.93%
3-Year Total Return
-99.93%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $0.3666
52-week High
May 03, 2024 - $108.00
Valuation
Market Cap
$2.43M - Nano Cap
Enterprise Value
$1.80M
Price/Sales (TTM)
--
Price/Book (Q)
-0.27
Dividends and Shares
Shares Outstanding
276.80K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.psyencebiomed.com
Phone Number
416-346-7764
Address
121 Richmond Street West
Toronto, ON M5H2K1
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients... more
NASDAQ 04/28/2025 3:59PM Eastern Quotes delayed